A Real-world Analysis of Treatment Patterns for Cholinesterase Inhibitors and Memantine among Newly-diagnosed Alzheimer’s Disease Patients. Bent-Ennakhil, N., Coste, F., Xie, L., Aigbogun, M. S., Wang, Y., Kariburyo, F., Hartry, A., Baser, O., Neumann, P., & Fillit, H. Neurology and Therapy, 6(1):131–144, June, 2017. ![A Real-world Analysis of Treatment Patterns for Cholinesterase Inhibitors and Memantine among Newly-diagnosed Alzheimer’s Disease Patients [link]](https://bibbase.org/img/filetypes/link.svg "link")
Paper doi abstract bibtex Introduction: Alzheimer’s disease (AD) is the most common neurodegenerative form of dementia. Pharmacological therapies for symptomatic treatment, such as acetylcholinesterase inhibitors (AChEIs) and memantine, have been available in the USA since 2000. Over the past decade, few studies have analyzed real-world anti-dementia treatment patterns in the USA. This study evaluated monotherapy AChEIs and memantine treatment patterns among newly diagnosed AD patients.
@article{bent-ennakhil_real-world_2017-1,
title = {A {Real}-world {Analysis} of {Treatment} {Patterns} for {Cholinesterase} {Inhibitors} and {Memantine} among {Newly}-diagnosed {Alzheimer}’s {Disease} {Patients}},
volume = {6},
issn = {2193-8253, 2193-6536},
url = {http://link.springer.com/10.1007/s40120-017-0067-7},
doi = {10.1007/s40120-017-0067-7},
abstract = {Introduction: Alzheimer’s disease (AD) is the most common neurodegenerative form of dementia. Pharmacological therapies for symptomatic treatment, such as acetylcholinesterase inhibitors (AChEIs) and memantine, have been available in the USA since 2000. Over the past decade, few studies have analyzed real-world anti-dementia treatment patterns in the USA. This study evaluated monotherapy AChEIs and memantine treatment patterns among newly diagnosed AD patients.},
language = {en},
number = {1},
urldate = {2020-10-23},
journal = {Neurology and Therapy},
author = {Bent-Ennakhil, Nawal and Coste, Florence and Xie, Lin and Aigbogun, Myrlene Sanon and Wang, Yuexi and Kariburyo, Furaha and Hartry, Ann and Baser, Onur and Neumann, Peter and Fillit, Howard},
month = jun,
year = {2017},
pages = {131--144},
file = {Bent-Ennakhil et al. - 2017 - A Real-world Analysis of Treatment Patterns for Ch.pdf:/Users/neil.hawkins/Zotero/storage/X2N4DTDU/Bent-Ennakhil et al. - 2017 - A Real-world Analysis of Treatment Patterns for Ch.pdf:application/pdf},
}
Downloads: 0
{"_id":"6ZQbkuCQm2CPt4Mou","bibbaseid":"bentennakhil-coste-xie-aigbogun-wang-kariburyo-hartry-baser-etal-arealworldanalysisoftreatmentpatternsforcholinesteraseinhibitorsandmemantineamongnewlydiagnosedalzheimersdiseasepatients-2017","author_short":["Bent-Ennakhil, N.","Coste, F.","Xie, L.","Aigbogun, M. S.","Wang, Y.","Kariburyo, F.","Hartry, A.","Baser, O.","Neumann, P.","Fillit, H."],"bibdata":{"bibtype":"article","type":"article","title":"A Real-world Analysis of Treatment Patterns for Cholinesterase Inhibitors and Memantine among Newly-diagnosed Alzheimer’s Disease Patients","volume":"6","issn":"2193-8253, 2193-6536","url":"http://link.springer.com/10.1007/s40120-017-0067-7","doi":"10.1007/s40120-017-0067-7","abstract":"Introduction: Alzheimer’s disease (AD) is the most common neurodegenerative form of dementia. Pharmacological therapies for symptomatic treatment, such as acetylcholinesterase inhibitors (AChEIs) and memantine, have been available in the USA since 2000. Over the past decade, few studies have analyzed real-world anti-dementia treatment patterns in the USA. This study evaluated monotherapy AChEIs and memantine treatment patterns among newly diagnosed AD patients.","language":"en","number":"1","urldate":"2020-10-23","journal":"Neurology and Therapy","author":[{"propositions":[],"lastnames":["Bent-Ennakhil"],"firstnames":["Nawal"],"suffixes":[]},{"propositions":[],"lastnames":["Coste"],"firstnames":["Florence"],"suffixes":[]},{"propositions":[],"lastnames":["Xie"],"firstnames":["Lin"],"suffixes":[]},{"propositions":[],"lastnames":["Aigbogun"],"firstnames":["Myrlene","Sanon"],"suffixes":[]},{"propositions":[],"lastnames":["Wang"],"firstnames":["Yuexi"],"suffixes":[]},{"propositions":[],"lastnames":["Kariburyo"],"firstnames":["Furaha"],"suffixes":[]},{"propositions":[],"lastnames":["Hartry"],"firstnames":["Ann"],"suffixes":[]},{"propositions":[],"lastnames":["Baser"],"firstnames":["Onur"],"suffixes":[]},{"propositions":[],"lastnames":["Neumann"],"firstnames":["Peter"],"suffixes":[]},{"propositions":[],"lastnames":["Fillit"],"firstnames":["Howard"],"suffixes":[]}],"month":"June","year":"2017","pages":"131–144","file":"Bent-Ennakhil et al. - 2017 - A Real-world Analysis of Treatment Patterns for Ch.pdf:/Users/neil.hawkins/Zotero/storage/X2N4DTDU/Bent-Ennakhil et al. - 2017 - A Real-world Analysis of Treatment Patterns for Ch.pdf:application/pdf","bibtex":"@article{bent-ennakhil_real-world_2017-1,\n\ttitle = {A {Real}-world {Analysis} of {Treatment} {Patterns} for {Cholinesterase} {Inhibitors} and {Memantine} among {Newly}-diagnosed {Alzheimer}’s {Disease} {Patients}},\n\tvolume = {6},\n\tissn = {2193-8253, 2193-6536},\n\turl = {http://link.springer.com/10.1007/s40120-017-0067-7},\n\tdoi = {10.1007/s40120-017-0067-7},\n\tabstract = {Introduction: Alzheimer’s disease (AD) is the most common neurodegenerative form of dementia. Pharmacological therapies for symptomatic treatment, such as acetylcholinesterase inhibitors (AChEIs) and memantine, have been available in the USA since 2000. Over the past decade, few studies have analyzed real-world anti-dementia treatment patterns in the USA. This study evaluated monotherapy AChEIs and memantine treatment patterns among newly diagnosed AD patients.},\n\tlanguage = {en},\n\tnumber = {1},\n\turldate = {2020-10-23},\n\tjournal = {Neurology and Therapy},\n\tauthor = {Bent-Ennakhil, Nawal and Coste, Florence and Xie, Lin and Aigbogun, Myrlene Sanon and Wang, Yuexi and Kariburyo, Furaha and Hartry, Ann and Baser, Onur and Neumann, Peter and Fillit, Howard},\n\tmonth = jun,\n\tyear = {2017},\n\tpages = {131--144},\n\tfile = {Bent-Ennakhil et al. - 2017 - A Real-world Analysis of Treatment Patterns for Ch.pdf:/Users/neil.hawkins/Zotero/storage/X2N4DTDU/Bent-Ennakhil et al. - 2017 - A Real-world Analysis of Treatment Patterns for Ch.pdf:application/pdf},\n}\n\n","author_short":["Bent-Ennakhil, N.","Coste, F.","Xie, L.","Aigbogun, M. S.","Wang, Y.","Kariburyo, F.","Hartry, A.","Baser, O.","Neumann, P.","Fillit, H."],"bibbaseid":"bentennakhil-coste-xie-aigbogun-wang-kariburyo-hartry-baser-etal-arealworldanalysisoftreatmentpatternsforcholinesteraseinhibitorsandmemantineamongnewlydiagnosedalzheimersdiseasepatients-2017","role":"author","urls":{"Paper":"http://link.springer.com/10.1007/s40120-017-0067-7"},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/f/FfNE7kWA6pCvwcJZF/myPubs.bib","dataSources":["ZaHtWavQhcwZqKLNF","iRRNaRs6FkffgErta","v8uQmZsBpiqycmskv"],"keywords":[],"search_terms":["real","world","analysis","treatment","patterns","cholinesterase","inhibitors","memantine","newly","diagnosed","alzheimer","disease","patients","bent-ennakhil","coste","xie","aigbogun","wang","kariburyo","hartry","baser","neumann","fillit"],"title":"A Real-world Analysis of Treatment Patterns for Cholinesterase Inhibitors and Memantine among Newly-diagnosed Alzheimer’s Disease Patients","year":2017}